Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Deborah, Langat"'
Autor:
Umesh G Lalloo, Lauren Komarow, Judith A Aberg, David B Clifford, Evelyn Hogg, Ashley McKhann, Aggrey Bukuru, David Lagat, Sandy Pillay, Vidya Mave, Khuanchai Supparatpinyo, Wadzanai Samaneka, Deborah Langat, Eduardo Ticona, Sharlaa Badal-Faesen, Robert A Larsen, ACTG A5225 Team
Publikováno v:
PLoS ONE, Vol 18, Iss 2, p e0281580 (2023)
BackgroundThe WHO recommended 1200mg/day of fluconazole (FCZ) in the induction phase of cryptococcal meningitis (CM) in HIV prior to 2018 in regions where amphotericin-B (AMB) was unavailable. A 2-stage AMB-controlled, dose-escalation study to determ
Externí odkaz:
https://doaj.org/article/d5c2b08341f74d62a664c9a9098c7601
Autor:
Michelle M. Pham, Anthony T. Podany, Noluthando Mwelase, Khuanchai Supparatpinyo, Lerato Mohapi, Amita Gupta, Wadzanai Samaneka, Ayotunde Omoz-Oarhe, Deborah Langat, Constance A. Benson, Richard E. Chaisson, Susan Swindells, Courtney V. Fletcher
Publikováno v:
Antimicrob Agents Chemother
The Brief Rifapentine–Isoniazid Efficacy for TB Prevention/A5279 trial demonstrated a 1-month daily regimen of rifapentine and isoniazid was noninferior to 9 months of isoniazid alone for preventing TB in persons living with HIV (PLWH). Our objecti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a5155110206af468bcf2d73718baafa3
https://doi.org/10.1128/aac.02385-21
https://doi.org/10.1128/aac.02385-21
Autor:
Deborah Langat, Jyoti S. Mathad, Jennifer Norman, Amita Gupta, Impaact Study Team, Lubbe Wiesner, Stephanie Popson, Nahida Chakhtoura, Nan Zhang, Kelly E. Dooley, Tsungai Chipato, Amphan Chalermchockcharoentkit, Portia Kamthunzi, Ellen Townley, Priya Jayachandran, Rada M. Savic, Sarah Bradford, Grace Montepiedra, Paula Britto, Vanessa Rouzier, Sandesh Patil
Publikováno v:
Clinical Infectious Diseases. 74:1604-1613
Background Pregnancy increases the risk of tuberculosis and its complications. A 3-month regimen of weekly isoniazid and rifapentine (3HP) is safe and effective for tuberculosis prevention in adults and children, including those with HIV, but 3HP has
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a9e93494243b6f535fd2b75eb193c27b
https://doi.org/10.1093/cid/ciab665
https://doi.org/10.1093/cid/ciab665
Autor:
Amita, Gupta, Xin, Sun, Sonya, Krishnan, Mitch, Matoga, Samuel, Pierre, Katherine, McIntire, Lucy, Koech, Sharlaa, Faesen, Cissy, Kityo, Sufia S, Dadabhai, Kogieleum, Naidoo, Wadzanai P, Samaneka, Javier R, Lama, Valdilea G, Veloso, Vidya, Mave, Umesh, Lalloo, Deborah, Langat, Evelyn, Hogg, Gregory P, Bisson, Johnstone, Kumwenda, Mina C, Hosseinipour
Publikováno v:
Open forum infectious diseases. 9(7)
Background People with human immunodeficiency virus (HIV) and advanced immunosuppression initiating antiretroviral therapy (ART) remain vulnerable to tuberculosis (TB) and early mortality. To improve early survival, isoniazid preventive therapy (IPT)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::559018f61438cca1906c8bfddaa48905
https://pubmed.ncbi.nlm.nih.gov/35899273
https://pubmed.ncbi.nlm.nih.gov/35899273
Autor:
Susan Swindells, Ritesh Ramchandani, Amita Gupta, Constance A. Benson, Jorge Leon-Cruz, Noluthando Mwelase, Marc A. Jean Juste, Javier R. Lama, Javier Valencia, Ayotunde Omoz-Oarhe, Khuanchai Supparatpinyo, Gaerolwe Masheto, Lerato Mohapi, Rodrigo O. da Silva Escada, Sajeeda Mawlana, Peter Banda, Patrice Severe, James Hakim, Cecilia Kanyama, Deborah Langat, Laura Moran, Janet Andersen, Courtney V. Fletcher, Eric Nuermberger, Richard E. Chaisson
Publikováno v:
New England Journal of Medicine. 380:1001-1011
Background Tuberculosis is the leading killer of patients with human immunodeficiency virus (HIV) infection. Preventive therapy is effective, but current regimens are limited by poor implementation and low completion rates. Methods We conducted a ran
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d34203686e53a6cbfd4d0b074c984977
https://doi.org/10.1056/nejmoa1806808
https://doi.org/10.1056/nejmoa1806808
Autor:
Deborah Langat, Virginia Sheikh, Martyn A. French, Rachel Bishop, Jintanat Ananworanich, Josphat Kosgei, Erin E. Gabriel, Martha Nason, Alice Pau, Adam Rupert, JoAnn M. Mican, Jing Wang, Irini Sereti, Douglas Shaffer, Nitiya Chomchey, Fredrick Sawe, Somsit Tansuphaswadikul, Nittaya Phanuphak, Nipat Teeratakulpisarn, Gregg Roby, Brian K. Agan, Fredrick Kirui, Hellen Ngeno
Publikováno v:
Clinical infectious diseases, 71(3), 652-660. Oxford University Press
Clin Infect Dis
Clin Infect Dis
Background Patients living with human immunodeficiency virus (PLWH) with low CD4 counts are at high risk for immune reconstitution inflammatory syndrome (IRIS) and death at antiretroviral therapy (ART) initiation. Methods We investigated the clinical
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce7dbfc5253a7a24f017a73f4352fdad
https://pure.amc.nl/en/publications/prospective-international-study-of-incidence-and-predictors-of-immune-reconstitution-inflammatory-syndrome-and-death-in-people-living-with-human-immunodeficiency-virus-and-severe-lymphopenia(c9d0912d-e50c-4d1b-9e12-9f444a89e168).html
https://pure.amc.nl/en/publications/prospective-international-study-of-incidence-and-predictors-of-immune-reconstitution-inflammatory-syndrome-and-death-in-people-living-with-human-immunodeficiency-virus-and-severe-lymphopenia(c9d0912d-e50c-4d1b-9e12-9f444a89e168).html
Autor:
Dirk P. Dittmer, Thomas B. Campbell, Otoniel Martinez-Maza, Jeffrey N. Martin, Mina C. Hosseinipour, Amc React-Ks Team, Aggrey Bukuru, Minhee Kang, Agnes Moses, Margaret Borok, Susan E. Krown, Catherine Godfrey, Brenda Hoagland, Mostafa Nokta, Mulinda Nyirenda, Richard F. Ambinder, Rosie Mngqbisa, Deborah Langat, Triin Umbleja, Wadzanai Samaneka, Noluthando Mwelase, Naftali Busakhala, John MacRae, Jackson Orem
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, vol 67, iss 2
Background Mild-to-moderate AIDS-associated Kaposi sarcoma (KS) often responds to antiretroviral therapy (ART) alone; the role of chemotherapy is unclear. We assessed the impact of immediate vs as-needed oral etoposide (ET) among human immunodeficien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::81655fafa6543c2719050f997875c7df
https://europepmc.org/articles/PMC6030807/
https://europepmc.org/articles/PMC6030807/
Publikováno v:
Open Forum Infectious Diseases. 2023 Supplement, Vol. 10, pS1-S1274. 3913p.
Autor:
Lalloo, Umesh G.1 (AUTHOR) umeshlalloo@gmail.com, Komarow, Lauren2 (AUTHOR), Aberg, Judith A.3 (AUTHOR), Clifford, David B.4 (AUTHOR), Hogg, Evelyn5 (AUTHOR), McKhann, Ashley2 (AUTHOR), Bukuru, Aggrey6 (AUTHOR), Lagat, David7 (AUTHOR), Pillay, Sandy1 (AUTHOR), Mave, Vidya8 (AUTHOR), Supparatpinyo, Khuanchai9 (AUTHOR), Samaneka, Wadzanai10 (AUTHOR), Langat, Deborah11 (AUTHOR), Ticona, Eduardo12 (AUTHOR), Badal-Faesen, Sharlaa13 (AUTHOR), Larsen, Robert A.14 (AUTHOR)
Publikováno v:
PLoS ONE. 2/13/2023, Vol. 17 Issue 2, p1-21. 21p.
Autor:
Gupta, Amita1 (AUTHOR) agupta25@jhmi.edu, Sun, Xin2 (AUTHOR), Krishnan, Sonya1 (AUTHOR), Matoga, Mitch3 (AUTHOR), Pierre, Samuel4 (AUTHOR), McIntire, Katherine1 (AUTHOR), Koech, Lucy5 (AUTHOR), Faesen, Sharlaa6 (AUTHOR), Kityo, Cissy7 (AUTHOR), Dadabhai, Sufia S1,8 (AUTHOR), Naidoo, Kogieleum9,10 (AUTHOR), Samaneka, Wadzanai P11 (AUTHOR), Lama, Javier R12 (AUTHOR), Veloso, Valdilea G13 (AUTHOR), Mave, Vidya1,14 (AUTHOR), Lalloo, Umesh15 (AUTHOR), Langat, Deborah5 (AUTHOR), Hogg, Evelyn16 (AUTHOR), Bisson, Gregory P17 (AUTHOR), Kumwenda, Johnstone18 (AUTHOR)
Publikováno v:
Open Forum Infectious Diseases. Jul2022, Vol. 9 Issue 7, p1-9. 9p.